| The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis K Riazi, H Azhari, JH Charette, FE Underwood, JA King, EE Afshar, ... The lancet gastroenterology & hepatology 7 (9), 851-861, 2022 | 2259 | 2022 |
| Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factorα signaling during peripheral organ inflammation C D'Mello, T Le, MG Swain Journal of Neuroscience 29 (7), 2089-2102, 2009 | 822 | 2009 |
| Global incidence of acute pancreatitis is increasing over time: a systematic review and meta-analysis JP Iannuzzi, JA King, JH Leong, J Quan, JW Windsor, D Tanyingoh, ... Gastroenterology 162 (1), 122-134, 2022 | 789 | 2022 |
| Fatigue in chronic disease MG Swain Clinical science 99 (1), 1-8, 2000 | 603 | 2000 |
| A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin MG Swain, MY Lai, ML Shiffman, WGE Cooksley, S Zeuzem, DT Dieterich, ... Gastroenterology 139 (5), 1593-1601, 2010 | 521 | 2010 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 494 | 2020 |
| Ribavirin as therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial AM Di Bisceglie, HS Conjeevaram, MW Fried, R Sallie, Y Park, ... Annals of internal medicine 123 (12), 897-903, 1995 | 480 | 1995 |
| Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial NV Bergasa, DW Alling, TL Talbot, MG Swain, C Yurdaydin, ML Turner, ... Annals of internal medicine 123 (3), 161-167, 1995 | 427 | 1995 |
| A pilot study of ribavirin therapy for chronic hepatitis C AM di Bisceglie, M Shindo, TL Fong, MW Fried, MG Swain, NV Bergasa, ... Hepatology 16 (3), 649-654, 1992 | 384 | 1992 |
| Environmental stress–induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat JB Meddings, MG Swain Gastroenterology 119 (4), 1019-1028, 2000 | 364 | 2000 |
| Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation DM McCafferty, JS Mudgett, MG Swain, P Kubes Gastroenterology 112 (3), 1022-1027, 1997 | 346 | 1997 |
| The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 294 | 2022 |
| Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression AD Frolkis, IA Vallerand, AA Shaheen, MW Lowerison, MG Swain, ... Gut 68 (9), 1606-1612, 2019 | 250 | 2019 |
| Efficacy and safety of elafibranor in primary biliary cholangitis KV Kowdley, CL Bowlus, C Levy, US Akarca, MR Alvares-da-Silva, ... New England Journal of Medicine 390 (9), 795-805, 2024 | 246 | 2024 |
| Immune-to-brain communication pathways in inflammation-associated sickness and depression C D’Mello, MG Swain Inflammation-associated depression: Evidence, mechanisms and implications, 73-94, 2016 | 246 | 2016 |
| Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence CB Appleyard, DM McCafferty, AW Tigley, MG Swain, JL Wallace American Journal of Physiology-Gastrointestinal and Liver Physiology 270 (1 …, 1996 | 234 | 1996 |
| Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis CS Bonder, MN Ajuebor, LD Zbytnuik, P Kubes, MG Swain The Journal of Immunology 172 (1), 45-53, 2004 | 230 | 2004 |
| Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised … D Jones, PF Boudes, MG Swain, CL Bowlus, MR Galambos, BR Bacon, ... The lancet Gastroenterology & hepatology 2 (10), 716-726, 2017 | 224 | 2017 |
| Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy KW Burak, MG Swain, T Santodomino-Garzon, SS Lee, SJ Urbanski, ... Canadian Journal of Gastroenterology and Hepatology 27 (5), 273-280, 2013 | 219 | 2013 |
| Open‐label trial of oral nalmefene therapy for the pruritus of cholestasis NV Bergasa, JM Schmitt, TL Talbot, DW Alling, MG Swain, ML Turner, ... Hepatology 27 (3), 679-684, 1998 | 219 | 1998 |
carla coffinProfessor of MedicineVerified email at ucalgary.ca
